Goodrich Katherine 4

4 · Tarsus Pharmaceuticals, Inc. · Filed Jun 16, 2026

AI-generated summary of this filing

Updated Jun 16, 2026

Tarsus (TARS) Director Katherine Goodrich Receives 2,954 RSU Shares

What Happened

Katherine Goodrich, a Tarsus Pharmaceuticals (TARS) non-employee director, had 2,954 restricted stock units (RSUs vest) converted into 2,954 shares on June 12, 2026 (transaction code M = exercise/conversion of derivative). The filing shows an immediate disposition of 2,954 shares at $0.00 (also coded M), which typically reflects shares withheld or surrendered to the company to satisfy tax withholding obligations following RSU settlement.

Key Details

Transaction date: 2026-06-12.
Acquired: 2,954 shares via settlement of vested RSUs (no cash price reported).
Disposed: 2,954 shares at $0.00 (derivative disposition) — commonly indicates share withholding for taxes.
Footnotes: RSUs were granted on 2026-06-12? (grant date per filing: June 12, 2025) and vested in full on the one-year anniversary (per F1–F3). Each RSU equals one share.
Filing date: 2026-06-16 — filed within the Form 4 two-business-day window (timely).
Shares owned after the transactions: not specified in the provided filing details.

Context

This was an RSU settlement for a director, not an open-market buy or sell. The simultaneous $0.00 disposition is a routine administrative step (net/share withholding) to satisfy tax obligations and does not necessarily indicate a market-directional trade by the insider.

Form 4

Period: 2026-06-12

Director

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-06-12+2,954→ 5,187 total
Exercise/Conversion
Restricted Stock Units
[F2][F3]
2026-06-12−2,954→ 0 total
→ Common Stock (2,954 underlying)

Footnotes (3)

[F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
[F2]Each RSU represents a contingent right to receive one share of the Company's common stock.
[F3]RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Signature

/s/ Jeffrey Farrow, Attorney-in-Fact|2026-06-16

1 file